Inflammatory myofibroblastic tumor of the bladder in children: what can be expected?

C H Houben1, A Chan, K H Lee

  • 1Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, Hong Kong. chhouben@web.de

Insights

Inflammatory myofibroblastic tumor (IMT) of the bladder is rare in children and mimics sarcoma. Conservative surgery is the preferred treatment, with no observed recurrences in a 1.5-year follow-up.

Area of Science:

  • Pediatric Oncology
  • Uropathology
  • Surgical Oncology

Background:

  • Inflammatory myofibroblastic tumor (IMT) of the bladder is an uncommon neoplastic condition with unknown potential.
  • In children, IMT often presents idiopatically, clinically and radiologically resembling sarcoma.
  • Distinguishing IMT from sarcoma is critical for appropriate management.

Observation:

  • A case study of a 10-year-old girl with bladder IMT is presented.
  • Histological and immunohistochemical features are detailed for differential diagnosis.
  • A meta-analysis identified 35 pediatric bladder IMT cases from the literature.

Findings:

  • Conservative surgical resection is the recommended treatment strategy for pediatric bladder IMT.
  • The meta-analysis revealed no evidence of recurrence or metastasis.
  • The median follow-up duration was 1.5 years.

Implications:

  • Conservative surgery offers a favorable prognosis for pediatric bladder IMT.
  • Accurate histological and immunohistochemical analysis is crucial for differentiating IMT from pediatric bladder sarcomas.
  • This study supports conservative management as the optimal approach for this rare pediatric tumor.